In a bombshell video exposé released by Project Veritas earlier this year, a Pfizer director of research and development spoke openly about the "revolving door" between government and pharmaceutical companies—an arrangement that's "pretty good for the industry but bad for everyone else in America."
When asked to clarify, he told the undercover PV journalist, "Because if the regulators, who review our drugs, you know that once they stop being a regulator, they want to go work for the company, they are not going to be as harsh on the company where they're getting their job."
One look at where former top officials went after leaving the government confirms this.
Former FDA commissioner Mark McClellan went over to Johnson & Johnson, another former FDA commissioner, Scott Gottlieb, is now at Pfizer, while former FDA commissioner Stephen Hahn is currently in a chief medical officer role at Flagship Pioneering, the investor behind Moderna. And these are just a few examples.
Most recently, former White House COVID adviser Dr. Deborah Birx, who worked in the federal government for decades, has been added to this "revolving door" list.
Earlier this month, Birx was appointed CEO of Armata Pharmaceuticals, a California-based biotech company focused on the development of bacteriophage therapeutics that help treat antibiotic-resistant bacterial infections.
"I am thrilled to join Armata at this pivotal time in the Company's development," Birx said in a statement. "I'm impressed with the scientific platform's quality and the team's commitment to introducing innovative treatment options for patients suffering from serious bacterial infections. I am excited about the recent advances and see multiple opportunities to accelerate the Company's progress and drive value creation. The recent investment enables the advancement of AP‐PA02 and AP‐SA02 in Phase 2 clinical trials."
Govt agency leaders are part of the bio-pharmaceutical complex. The syndicate rewards members with high-paying positions as they move within the complex. @US_FDA @CDCgov @NIH @HHSGov staff bump up to NGO/pharma after currying favor in office. https://t.co/39N17TGtQ9 https://t.co/ZY9YVjqHro pic.twitter.com/upTqEXVt6R
— Peter A. McCullough, MD, MPH™ (@P_McCulloughMD) July 22, 2023
🥴 The revolving door of Big Pharma and Government conflicts of interest 🤨💵 https://t.co/7xGQqwb7rg
— Cheryl 🇺🇸🏕 (@CPoppino) July 22, 2023
See how the game works?
— AmericanBadAss🇺🇸 (@Amer_icanbadass) July 22, 2023
This behavior should be banned. https://t.co/BwZSCZSC0m
This is what we call the "revolving door." https://t.co/pEgPmxK6OG
— Megan Redshaw (@megan_redshaw) July 23, 2023
